Flecainide Acetate - Latest Advances

Reviewing the use of antiarrhythmic drugs in elderly patients with atrial fibrillation.

Journal: Expert review of cardiovascular therapy

Published: September 17, 2025

Expanding the indications for flecainide: Good idea or CAST reprise?

Journal: Heart rhythm

Published: September 15, 2025

Implantable Cardioverter Defibrillators for Long QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia? (Not so fast, Louis).

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 15, 2025

Accessory-pathway-mediated dilated cardiomyopathy in an infant.

Journal: Cardiology in the young

Published: August 26, 2025

ECG findings in fatal flecainide intoxication.

Journal: BMJ case reports

Published: August 14, 2025

Left bundle branch block on flecainide in Wolff-Parkinson-white syndrome.

Journal: Journal of electrocardiology

Published: August 12, 2025

Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.

Journal: Journal of cardiovascular pharmacology

Published: July 24, 2025

Flecainide in structural heart diseases: A contemporary reappraisal beyond the CAST.

Journal: Heart rhythm

Published: July 21, 2025

Orally Inhaled Flecainide for Paroxysmal Atrial Fibrillation: Emerging Evidence and Therapeutic Potential in Cardioversion to Sinus Rhythm.

Journal: Cardiology in review

Published: July 17, 2025

CRISPR activation to repair ECG abnormalities caused by a FLNC truncating variant in mice.

Journal: European heart journal

Published: July 09, 2025

Decreased RYR2 Cluster Size and Abnormal SR Ca2+ Release Contribute to Arrhythmogenesis in TMEM43-Related ARVC.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 30, 2025

Loss of atrial capture resulting in hemodynamic compromise in the context of flecainide and amiodarone administration with normal electrolyte function.

Journal: HeartRhythm case reports

Published: June 25, 2025

Filters

Reviewing the use of antiarrhythmic drugs in elderly patients with atrial fibrillation.

Reviewing the use of antiarrhythmic drugs in elderly patients with atrial fibrillation.

Expanding the indications for flecainide: Good idea or CAST reprise?

Expanding the indications for flecainide: Good idea or CAST reprise?

Implantable Cardioverter Defibrillators for Long QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia? (Not so fast, Louis).

Implantable Cardioverter Defibrillators for Long QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia? (Not so fast, Louis).

Accessory-pathway-mediated dilated cardiomyopathy in an infant.

Accessory-pathway-mediated dilated cardiomyopathy in an infant.

ECG findings in fatal flecainide intoxication.

ECG findings in fatal flecainide intoxication.

Left bundle branch block on flecainide in Wolff-Parkinson-white syndrome.

Left bundle branch block on flecainide in Wolff-Parkinson-white syndrome.

Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.

Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.

Flecainide in structural heart diseases: A contemporary reappraisal beyond the CAST.

Flecainide in structural heart diseases: A contemporary reappraisal beyond the CAST.

Orally Inhaled Flecainide for Paroxysmal Atrial Fibrillation: Emerging Evidence and Therapeutic Potential in Cardioversion to Sinus Rhythm.

Orally Inhaled Flecainide for Paroxysmal Atrial Fibrillation: Emerging Evidence and Therapeutic Potential in Cardioversion to Sinus Rhythm.

CRISPR activation to repair ECG abnormalities caused by a FLNC truncating variant in mice.

CRISPR activation to repair ECG abnormalities caused by a FLNC truncating variant in mice.

Decreased RYR2 Cluster Size and Abnormal SR Ca2+ Release Contribute to Arrhythmogenesis in TMEM43-Related ARVC.

Decreased RYR2 Cluster Size and Abnormal SR Ca2+ Release Contribute to Arrhythmogenesis in TMEM43-Related ARVC.

Loss of atrial capture resulting in hemodynamic compromise in the context of flecainide and amiodarone administration with normal electrolyte function.

Loss of atrial capture resulting in hemodynamic compromise in the context of flecainide and amiodarone administration with normal electrolyte function.